From : EASL Office <easloffice@easloffice.eu>
To : eadamia@moh.gov.ge
Subject : Digital ILC | FREE access to Exhibition Hall & Industry Satellite Symposia
Received On : 01.10.2020 13:32

Digital ILC | FREE access to Exhibition Hall & Industry Satellite Symposia
1 October 2020

Dear member of the global liver community,

Our Digital International Liver Congress 2020, held 27–29 August 2020, has been a stellar success. Nearly 7,400 delegates from 114 countries around the world participated in this exciting, immersive event, rich in learning and networking. Delegates are logging in daily still, 24/7, to savour the on-demand contents. Are you one of them?

If you missed Digital ILC 2020, it’s not too late. We’re offering you, as a member of the international liver community, free access right now to the Exhibition Hall and the Industry Satellite Symposia.

Sign me up for free access to the Exhibition Hall & Industry Satellite Symposia
AbbVie | Albireo Pharma | Alfapump | Biotest AG | Dr. Falk Pharma GmbH | ENDRA LifeSciences, Inc | FibroScan® by Echosens | GE Healthcare | Gilead | GlaxoSmithKline | GMP-ORPHAN | Gore & Associates | Intercept | Madrigal Pharmaceuticals | Novartis | Novo Nordisk | PhoenixBio | Shionogi Europe | Siemens Healthineers | Sobi | Sonic Incytes |Virology Education
In the Exhibition Hall, you’ll find 22 sponsors and 27 stands. Browse the stands to view videos, read product updates, discover guidelines, explore R&D and emerging diagnostic tools, not to mention studies in the pipeline, and more. Network and connect with industry representatives, putting your questions to them. All this, entirely free and open access, easy to browse and download.
 
Get free access to the Industry Satellite Symposia & Mini-workshop
How can we accelerate HCV elimination in the current landscape?

Chair: Jean-Michel Pawlotsky (France)
Challenges in the management of patients with cholestatic liver diseases
Speakers: Ulrich Baumann (Germany), Patrick McKiernan (United States), Verena Keitel (Germany)
Evolving treatment landscape of hepatocellular carcinoma (HCC)

Chair: Bruno Sangro, Spain
A new virus in the mix: Re-imagining liver disease care in the COVID-19 era

Chair: Graham Foster (United Kingdom)
Albumin: a disease-modifying agent in decompensated cirrhosis

Chair: Alexander Gerbes (Germany)
Emerging trends in the care pathway for patients with NASH

Chairs: Rohit Loomba (United States) and Vlad Ratziu (France)
FXR agonism in clinical practice: new perspectives from the real-world experience in PBC

Chair: David Jones (United Kingdom)
Obesity management in NAFLD/NASH: Can we do more?

Chair: Rachel Batterham (United Kingdom)
NASH – the metabolic disease of the liver

Chair: Elisabetta Bugianesi (Italy)
Addressing the metabolic drivers of NASH

Speakers: Samuel Klein (United States) and Quentin Anstee (United Kingdom)
Avatrombopag for severe thrombocytopenia: paving the way for procedures in adult patients with CLD who are scheduled to undergo an invasive procedure
Chair: Markus Peck-Radosavljevic, Austria
Sign me up for free access to the Exhibition Hall & Industry Satellite Symposia
Keen to register for full access to absolutely everything at Digital ILC 2020? Enjoy on-demand content throughout the platform: 100+ hours of content, 98 sessions, 315 invited speakers, 11 industry symposia, 1,500+ abstracts, and more.

Already registered for Digital ILC 2020?

Then skip straight to the Exhibition Hall and Industry Satellite Symposia, using your login.


  
Download the EASL app 
Access event info, EASL Campus and stay informed with the latest messages and news.

  
For the latest news on COVID-19 and liver disease, follow us on Twitter

@EASLnews and @EASLedu
Twitter
Facebook
LinkedIn
Website
Share with a friend or colleague Share with a friend or colleague
EASL’s mission is supported by an unrestricted education grant from Abbvie and Bristol-Myers Squibb.

EASL, The Home of Hepatology

7 rue Daubin, 1203 Geneva, Switzerland

+41 22 807 03 60
www.easl.eu
easloffice@easloffice.eu

Update your preferences or unsubscribe